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Abstract  
 
Background and Objectives: Caffeine is an active adulterant found in several 
drugs of abuse including coca paste (CP). We had previously demonstrated that 
caffeine potentiated the acute stimulant effect induced by CP seized samples. 
The role of caffeine in the expression of sensitization elicited by a CP seized 
sample (CP1) was here evaluated.  
Methods: CP1 (equivalent dose of 10 mg/kg of cocaine), cocaine (pure, 10 
mg/kg), a combination of cocaine 10 mg/kg plus caffeine 2.5 mg/kg (CP1-
surrogate) and saline (control) were intraperitoneally injected in male rats under 
two different sensitization schedules. Ambulatory locomotion was recorded in 
58 animals.   
Results: After 5 daily CP1 injections and 5 days of withdrawal, CP1-challenged 
animals displayed a more robust sensitization than cocaine-treated animals. 
When a 3 injections-regime of CP1-surrogate or cocaine was assayed, only 
CP1-surrogate was able to elicit sensitization.  
Discussion and Conclusions: Caffeine enhances and accelerates the CP1-
induced sensitization.  
Scientific Significance: Results may shed light on the fast and high 
dependence observed in CP users.  
 
 
 
 
Keywords: Coca paste, Cocaine, Caffeine, Sensitization, Addiction 
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INTRODUCTION 
 
 Coca paste (CP) is an illicit drug of abuse which consumption has 
increased in recent years. Whilst worldwide crack is the most well-known form 
of cocaine used for smoking, CP is another smoked cocaine form commonly 
used in several South America countries1-3. CP can be differentiated from crack 
since CP is one of the earliest intermediate products obtained during the 
extraction of the alkaloid cocaine from coca leaves (Erythroxylon coca)1. As a 
result of this chemical process, cocaine hydrochloride is reached. In contrast, 
cocaine hydrochloride is used as a precursor for crack preparation4-6. CP 
contains a high, although variable amount of cocaine (base), low proportions of 
chemical substances such as kerosene, sulfuric acid, benzoic acid and other 
alkaloids which occur as a natural result of the extraction process1,7.  
 Like crack, CP is a low price drug, and although illegal, is readily 
available. In humans, consumption of CP produces an intense feeling of 
euphoria combined with psychomotor alterations. Common users of CP quickly 
develop a high level of dependence with high rates of relapse. Behavioral 
alterations such as cognitive deficits, increased levels of impulsivity and 
aggressiveness and sleep disturbances are also seen. These behavioral traits 
conform a clinical profile shared by all CP users2,8.  
 It has been proposed that the propensity to develop addiction to a 
particular drug depends on how fast the substance reaches the brain, 
determining the relevance of the route of administration9,10. This might be one 
reason why, for example, crack is thought to be more addictive than sniffed 
cocaine9,11. Although other factors should not be ruled out, it is possible that the 
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pulmonary inhalation used to consume CP could partially explain the high 
dependence/high rates of relapse observed in CP users.   
 We have previously reported that, as it happens with other illicit drugs of 
abuse12, CP seized samples contain passive (innocuous) and active 
adulterants13. Among active adulterants, caffeine, a natural xanthinic alkaloid, is 
one of the most commonly found13. In rodents, we have shown that the acute 
systemic administration of a series of CP seized samples obtained from police 
drug raid, has a significantly higher stimulant effect compared with purified 
cocaine (hydrochloride) administered under similar conditions (without 
adulterants). Interestingly, we determined that those CP seized samples 
adulterated with a high caffeine proportion induced the higher stimulant effect. 
We have proposed that the content of caffeine in CP seized samples should be 
taken into consideration when analyzing the pharmacological effects of CP13. 
 Caffeine is a legal substance consumed worldwide to improve attention 
and overall performance. Extensive use of caffeine may lead to the 
development of mild psychological and physical dependence14. Caffeine is 
found in many commercial products, but it is also used as an active adulterant 
in drugs of abuse6,12,15-17. It has been reported that street cocaine and 
methamphetamine contain caffeine not only to increase the volume and/or 
weight, but probably to enhance the reinforced property as well as the stimulant 
effect12,16. In addition, caffeine can be volatilized18, which would be one of the 
reasons why it is found as an adulterant in CP samples. However, little research 
on the consequences induced by caffeine in CP seized samples and the 
expression of the clinical profile seen in patients is available.  
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 It is known that an initial exposure to cocaine results in an increased 
motor activity, which is further enhanced after repeated administration and a 
following withdrawal period. This phenomenon known as sensitization can 
produce enduring molecular, cellular and behavioral changes that resemble 
some addiction-related features seen in humans19-22 and can predict the ability 
of the drug to reinstate drug-seeking behavior in rats21,22. The process of 
sensitization has an initiation phase in which animals display a gradual increase 
in the locomotion following daily cocaine administration. A second phase is 
characterized by a persistent hyper-responsiveness to the drug after cessation 
of administration and includes certain neuroadaptative modifications21-24.  
 The present work was designed to determine if a selected CP seized 
sample was able to evoke locomotor sensitization after a repeated 
administration schedule. As caffeine was the only active adulterant found in this 
CP seized sample13, its role in the rat’s locomotor sensitization was also 
evaluated. 
 
METHODS 
 
Animals 
 
 Wistar male rats (IIBCE animal facilities, Montevideo) weighing 250-310 
g were employed. All animals were housed in groups of 5 in plastic cages (50 
cm × 37.5 cm × 21 cm) and kept under controlled conditions (temperature 22 ± 
2°C, 12-h day-night cycle, lights on at 7:00 am) with food and water available ad 
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libitum. All procedures were approved by the IIBCE Bioethics Committee's 
requirements and carried out under the current national ethical regulations.  
 
Drugs  
 
 CP was supplied by the Technical Forensic Institute (Uruguay) from a 
seized drug shipment targeted for the Uruguayan illegal drug market, with the 
authorization of the National Drugs Board and the Ministry of Public Health 
(Uruguay). In the present study, CP1 was selected among a group of CP seized 
samples. Cocaine hydrochloride (pure) was generously donated by Laboratory 
Verardo  Cia (Argentina) and caffeine was obtained from Sigma Aldrich 
(Germany). CP1 was dissolved in a vehicle solution containing 2 % hydrochloric 
acid (HCl) and enough sodium hydroxide to titrate the solution to a pH of= 6.3. 
Cocaine hydrochloride and caffeine were dissolved in saline. A previous 
chemical analysis indicated that CP1 contained 68.9 % of cocaine base and 
15.0 % of caffeine. No other adulterants were found in CP1 and impurities were 
present in a very low proportion13. We have previously published data regarding 
the acute stimulant and neurochemical effect induced by this CP sample13. 
 
Experimental groups 
 
 CP1 was injected at an equivalent cocaine dose of 10 mg/kg (final dose 
13.0 mg/kg) and cocaine was administered at 10 and 5 mg/kg. Caffeine was 
administered alone at a dose of 2.5 mg/kg and the same dose (2.5 mg/kg) in 
combination with cocaine 10 or 5 mg/kg, respectively. Control animals were 
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injected with the corresponding vehicles. The volume of injection was set at 1 
ml/kg and corrected when equivalent doses were administered. Caffeine dose 
was calculated based on the percentage of caffeine content of CP113. A 
previous study showed that combination of cocaine and caffeine at doses 
equivalent to their content in CP1 exerted the same stimulant effect and that 
can be used as a valid surrogate to study its effects13. Here, we used the 
combination of cocaine (10 mg/kg) and caffeine (2.5 mg/kg) as a CP1-
surrogate.  
 
Behavioral assays 
 
 Measurement of locomotor sensitization was carried out in an Open Field 
(OF) paradigm (a square box of 60 × 60 cm with red 40-cm-high acrylic sides) in 
a quiet experimental room with controlled temperature (22 ± 2°C). Locomotor 
activity was recorded automatically by a camera connected to a computer 
equipped with the Ethovision XT 7.0 software (Noldus, the Netherlands). Using 
this video tracking software we specifically measured the horizontal locomotor 
activity defined as the total distance moved in meters (m). 
 To study the sensitization induced by CP1 and cocaine the following 
experimental protocol was applied: one day preceding drug treatment, animals 
were habituated to the OF over a 60 min period (day 0) in which basal 
locomotor activity was recorded. Later, animals were randomly assigned to 
different experimental groups which received CP1, cocaine and their respective 
vehicles daily for 5 days (Protocol I). On day 1 and 5, before the drug or vehicle 
injection, animals were allowed a 20 min habituation period in the OF prior drug 
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injection. Locomotor activity was assessed each day for 30 min starting 5 min 
after the drug or vehicle administration. After the last treatment, rats were kept 
in their home cages for a 5 days withdrawal period. On the eleventh day, 
animals were put in the OF for 20 min (habituation prior the drugs injection) and 
then received a challenge injection according the rat pretreatment. Locomotor 
activity was recorded for 30 min starting 5 min after the drug or vehicle 
administration (Fig. 1A shows the experimental schedule).  
 To study the role of caffeine in the expression of the CP1-induced 
sensitization a surrogate of CP1 was administered. The following experimental 
protocol was applied: one day preceding drug treatment animals were 
habituated to the OF over a 60 min period (day 0) in which basal locomotor 
activity was recorded. Later, animals were randomly assigned to the different 
experimental animal groups which received cocaine (10), caffeine (2.5 mg/kg) 
and a combination of cocaine and caffeine i.e. Coc(10) + Caff(2.5) (as a surrogate 
of CP1 at an equivalent cocaine dose of 10 mg/kg] and their respective vehicles 
daily for 3 days (Protocol II). Only on day 1 animals were allowed a 20 min 
habituation period in the OF prior drug injection. Locomotor activity was 
recorded each day for 60 min starting 5 min after the drug or vehicle 
administration. After the last treatment, the rats were kept in their home cages 
for a 5 days withdrawal period. On the ninth day, animals were put in the OF for 
20 min (habituation prior the drugs injection) and then received a challenge 
injection according the rat pretreatment. Locomotor activity was registered for 
60 min, 5 min after the drug or vehicle administration (Fig. 1B shows the 
experimental schedule).  
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 During all experiments the OF was cleaned with alcohol 30 % before 
placing the following rat. All experiments were done between 9 a.m. and 3 p.m. 
 
Statistical analysis 
 
 Data are given as Mean ± Standard Error of the Mean (SEM) and were 
analyzed by two-way (time and pretreatment) analysis of variance (ANOVA) for 
repeated measures followed by post hoc Newman-Keuls multiple comparison 
test and by one-way ANOVA for independent measures (treatment) followed by 
Newman-Keuls test. Statistical significance was set at P<0.05.  
 
RESULTS 
 
CP1- and cocaine-treated animals developed and expressed sensitization  
  
 Figure 2 A and B show the effect of CP1 and cocaine treatment in 
locomotor activity during 5 days and on challenge day. In Fig. 2A, two-way 
ANOVA revealed a significant effect of the treatment [F(3,15)= 35.92, P < 0.0001] 
but not for time [F(4,60)= 2.05, P = 0.09] or the treatment x time interaction 
[F(12,60)= 1.37, P = 0.20]. Results of post-hoc Newman-Keuls suggest that a 
development of sensitization was achieved after the repeated injection of CP1 
and cocaine since a gradual rise in the distance moved was observed in both 
groups in comparison with their respective controls (Fig. 2A), although some 
differences were observed. In the case of CP1-treated animals the increase in 
the locomotor activity reached statistical significance from the second to the fifth 
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day, whereas in cocaine-pretreated animals the effect was statistically 
significant only on the last day of the treatment. Additionally, a maximum 
difference between drugs was evidenced on the third day (Fig. 2A). In Fig. 2B, 
one-way ANOVA followed by Newman-Keuls revealed that both CP1- and 
cocaine-treated animals (P < 0.01 and P < 0.05, respectively) were able to 
express the sensitization phenomenon. However, a significant difference 
between CP1 and cocaine (P < 0.01) could be observed. The effect of the CP1 
challenge on the locomotor activity of the CP1-pretreated animals was 
significantly higher than that induced by cocaine injection in cocaine-pretreated 
animals (Fig. 2B). There were no statistical differences during the initiation or 
expression phase in vehicle-treated animals and challenged with both drugs 
(Fig. 2 A and B). 
 
Caffeine accelerated and enhanced the sensitization induced by cocaine  
  
 In order to confirm whether the presence of caffeine in CP1 could 
accelerate and enhance the development and expression of sensitization, 
another group of animals was treated with a combination of cocaine and 
caffeine at doses equivalent to their content in CP1 (i.e. CP1-surrogate) and the 
effect of its repeated administration on animal locomotion was compared with 
that induced by cocaine alone (Fig. 3 A and B). In Fig. 3A, two-way ANOVA 
revealed a significant effect of the treatment [F(3,14)= 13.31, P < 0.001] but not 
for time [F(2,28)= 3.10, P = 0.06] or the treatment x time interaction [F(6,28)= 1.19, 
P = 0.33]. Post-hoc Newman-Keuls showed that the repeated injection of CP1 
surrogate or cocaine was able to induced a gradual and significant increase in 
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the distance moved along the days in comparison with their respective control 
groups (Fig. 3A), demonstrating a development of sensitization. A maximum 
difference between drugs was evidenced on the second day (P < 0.01; Fig. 2A). 
In Fig. 3B, one-way ANOVA followed by Newman-Keuls revealed that while 
cocaine-treated animals seemed to develop sensitization (Fig. 3A) these 
animals did not express sensitization when challenged with cocaine (Fig. 3B). In 
contrast, a significant effect on the locomotor activity of CP1-surrogate-treated 
animals was observed compared with the control group (P < 0.05). Moreover, 
CP1-surrogate induced a more robust effect on animal locomotion compared 
with cocaine-challenged animals, demonstrating a great influence of caffeine in 
the expression of the sensitization elicited by CP1 surrogate (Fig. 3B). There 
were no statistical differences during the initiation or expression phase in saline-
treated animals challenged with cocaine or CP1 surrogate (Fig. 3 and B). 
Moreover, sensitization was not observed in animals pre-treated with caffeine 
(2.5 mg/kg) or vehicle and challenged with caffeine (2.5 mg/kg; data not 
shown). 
 Accordingly with the finding obtained above and in order to continue 
studying the influence of caffeine in the development and expression of 
sensitization induced by cocaine (and indirectly by CP1), another group of 
animals was treated with a combination of a lower dose of cocaine (5 mg/kg) 
and the same dose of caffeine (2.5 mg/kg). In Fig. 4A, two-way ANOVA 
revealed a significant effect of the treatment [F(3,17)= 31.49, P < 0.0001] but not 
for time [F(2,34)= 2.88, P = 0.07] or the treatment x time interaction [F(6,34)= 1.40, 
P = 0.24]. Post-hoc Newman-Keuls showed that only those animals treated with 
cocaine (5 mg/kg) plus caffeine (2.5 mg/kg) were able to developed 
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sensitization. A gradual increase in distance moved was observed in animals 
treated with cocaine (5 mg/kg) plus caffeine (2.5 mg/kg) compared with the 
corresponding control group. Cocaine (5 mg/kg) did not modify the animal 
locomotion along days (Fig. 4A). In Fig. 4B, one-way ANOVA followed by 
Newman-Keuls revealed that only those animals which were pretreated with the 
combination of cocaine (5 mg/kg) plus caffeine (2.5 mg/kg) unchained the 
expression of sensitization (Fig. 4B). A significant increase in distance moved 
was observed in cocaine (5 mg/kg) plus caffeine (2.5 mg/kg)-treated animals 
compared with control group (P < 0.01) and also with cocaine alone (P < 0.001) 
indicating that caffeine seemed to facilitate the expression of the sensitization 
even in rats treated with a minor dose of cocaine. There were no statistical 
differences during the initiation or expression phase in vehicle-treated animals 
or challenged with cocaine or cocaine plus caffeine (Fig. 4 A and B). 
 
DISCUSSION 
 
 The present study demonstrated that rats repeatedly treated with 
CP1 displays a more robust behavioral sensitization than cocaine-treated 
animals suggesting an additive action of its main components, cocaine 
and caffeine. These observations agree with our previous report in which acute 
administration of a combination of cocaine and caffeine, reaching specific 
proportions in CP1, acted in an additive way, explaining the potent acute 
stimulant effect observed13. Here, we also demonstrated that the sensitization 
phenomenon is elicited even in animals treated with the CP1-surrogate during 3 
days. Both are important findings since they suggest that caffeine, as an active 
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adulterant in CP seized samples, could accelerate and enhance the 
neuroadaptations involved in behavioral sensitization. Considering that the 
occurrence of behavioral sensitization may predict the ability of a drug to induce 
reinstatement of drug-seeking behavior21,22, our results would add valuable 
information about the clinical outcome of CP consumers and the mechanisms 
underlying the high dependence observed in CP users. 
  Other studies have already demonstrated interaction between cocaine 
and caffeine23-25, although other paradigms were used and a pre-exposure of 
caffeine, even at higher doses than that used in our work, were assayed. 
Contrastingly, our results show the relevance of caffeine, even at a very low 
dose, in the induction of CP1 sensitization using a combined solution with 
cocaine (mimicking CP1).  
 Interestingly, during the development of CP1 sensitization, animals 
showed a progressive increase in locomotor activity until the third day. Then, a 
steady decrease was observed until the level of the distance moved of cocaine 
pre-treated animals was reached. This is probably due to the development of 
caffeine tolerance as previously described26. However, this did not abolish the 
expression of sensitization seen on the challenge (11th) day.  
 Molecular events underlying the additive action between cocaine and 
caffeine are not elucidated here although it is most likely to be mediated through 
a modulation of the dopaminergic (DAergic) and adenosinergic 
neurotransmission. Several evidences indicate that sensitization induced by 
cocaine involves modifications in DA transmission27. Cocaine blocks DA 
reuptake increasing DA neurotransmission in different brain regions, especially 
those involved in motor control and reward22. Specifically, the mesolimbic 
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DAergic system projecting from the ventral tegmental area to the nucleus 
accumenbs (NAcc) is believed to be related with the neural mechanism of 
sensitization, as well as the rewarding and addictive properties of cocaine28. On 
the other hand, caffeine is an unspecific antagonist of adenosine receptors, 
although it exerts its behavioral actions mainly through A1 and A2A receptors29. 
It is well-known that both A1 and A2A receptors co-localize with DA receptors in 
the NAcc medium spiny neurons influencing their activity29,30. Although the 
relative contribution of A1 and A2A receptors on the locomotor stimulant effect 
induced by caffeine has not yet been completely elucidated, some evidences 
suggest a predominant role of A2A receptors, especially at low caffeine doses31. 
Expression of A2A receptors is enriched in NAcc and dorsal striatum, while A1 
receptors are widely distributed through the brain but only moderately 
expressed in those areas30. Additionally, it was demonstrated that the specific 
A2A antagonist SCH58261 but not the A1 antagonist DPCPX increased the 
locomotor activity in rats to a similar extent than caffeine32. A2A receptor has 
also been associated with the regulation of cocaine-induced behavioral 
sensitization33. Accordingly, our findings agree with the evidences published by 
Filip and collaborators who have already postulated a putative mechanism to 
explain the enhancement of the expression of cocaine sensitization through an 
interaction between adenosine A2 receptors and D2 receptors33. Further studies 
should be done to measure the induction of intracellular proteins (e.g. DARPP-
32) or changes in protein expression of membrane receptors (A1 and A2 or D1 
and D2 receptors) under the experimental protocols used in the present paper. 
 When cocaine is smoked effects immediately appear suggesting that 
the drug is taken up into the brain more rapidly than intranasal cocaine11. 
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Although the biological and psychological effects of smoked and intranasal 
cocaine are similar, crack use has been associated with increased abuse9,11 
and the same is considered for CP consumption. Here, we demonstrated that 
caffeine content present in CP seized samples could potentiate the 
pharmacological effects induced by CP samples adulterated with caffeine. It 
might be suggested that under a fast route of administration (pulmonary 
inhalation) the use of CP seized samples containing caffeine (or other active 
adulterants) produces a more robust psychostimulant effect and increases the 
likelihood of craving, relapse and dependence. Accordingly, it has been 
hypothesized that the rapid delivery of a drug to the brain facilitates its 
capacity to induce forms of neurobehavioral plasticity, leading to a greater 
incentive motivation for the drug (i.e. sensitization) and contributing to its 
compulsive use10. Moreover, it has been reported that the production process 
of freebase cocaine and crack eliminated sugar and sugar alcohols (as volume 
adulterants) but all other cutting substances detected (e.g. caffeine, 
phenacetine, lidocaine, levamisol) were present in the cocaine base 
preparations since they were found in the smoke condensates in sufficient 
amounts34. This fact suggests that all these substances, especially caffeine, 
could reach the brain in CP consumers contributing to the addictive potential of 
CP.  
 Adulteration involves the intentional addition of pharmacologically active 
substances in an attempt to use less of the intended product without making the 
user aware. In agreement with this issue, our present results demonstrate that, 
although the amount of cocaine was lesser (5 mg/kg) the sensitization 
phenomenon also appears as the presence of caffeine (2.5 mg/kg) would 
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compensate this decrement, boosting equally the effect of cocaine. It is 
extremely interesting to know that recently the percentage of caffeine found in 
some CP seized samples is higher than the percentage of cocaine (unpublished 
data), indicating once again the relevance of adulterants in drugs of abuse.   
 In this study it was not determined if caffeine in CP seized samples really 
enhances the motivational value of the drug. Further experiments should be 
performed using specific paradigms such self-administration, to answer this 
question.  
 In conclusion, we demonstrated that the systemic and repeated 
administration of a CP seized sample elicited a sensitization phenomenon in 
rats. Our findings indicate also that the presence of caffeine substantially 
contribute to the development and elicitation of this phenomenon. Through this 
work we provide useful information about the factors implied in the 
pharmacological effect of CP. We also highlight the role of active adulterants 
commonly used in other illicit psychostimulants. Finally, our results agree with 
proposed mechanisms involving adenosinergic agonism for new treatment 
aimed to cocaine or CP addiction35. 
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